on October 7, 2004
Published online before print October 7, 2004, doi: 10.1161/01.STR.0000143730.29964.93
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 3, 2004
From the Division of Pharmacology, Department of Neuroscience, University of Naples "Federico II," Naples, Italy. * To whom correspondence should be addressed. E-mail: lannunzi{at}unina.it.
Background and Purpose--The Na+/Ca2+ exchanger, by mediating Ca2+ and Na+ fluxes in a bidirectional way across the synaptic plasma membrane, may play a pivotal role in the events leading to anoxic damage. In the brain, there are 3 different genes coding for 3 different proteins: NCX1, NCX2, and NCX3. The aim of this study was to determine whether NCX1, NCX2, and NCX3 might play a differential role in the development of cerebral injury induced by permanent middle cerebral artery occlusion (pMCAO). Methods--By means of Western blotting, NCX1, NCX2, and NCX3 protein expression was evaluated in the ischemic core and in the remaining nonischemic area of the slice at different time intervals starting from ischemia induction. The role of each isoform was also assessed with antisense oligodeoxynucleotides (ODNs) targeted for each isoform. These ODNs were continuously intracerebroventricularly infused with an osmotic minipump (1 µL/h) for 48 hours, 24 hours before pMCAO. Results--The results showed that after pMCAO all 3 NCX proteins were downregulated in ischemic core; NCX3 decreased in periinfarctual area whereas NCX1 and NCX2 were unchanged. The ODNs for NCX1 and NCX3 gene products were capable of inducing an increase in the ischemic lesion and to worsen neurological scores. Conclusions--The results of this study suggest that in the neuroprotective effect exerted by NCX during ischemic injury, the major role is prevalently exerted by NCX1 and NCX3 gene products.
Revised on July 21, 2004
Accepted on August 6, 2004
Two Sodium/Calcium Exchanger Gene Products, NCX1 and NCX3, Play a Major Role in the Development of Permanent Focal Cerebral Ischemia
Giuseppe Pignataro PhD;
Key words: neuroprotection • oligodeoxynucleotides, antisense • protein expression • sodium-calcium exchange
This article has been cited by other articles:
 |
|
 |
|
  L. Formisano, M. Saggese, A. Secondo, R. Sirabella, P. Vito, V. Valsecchi, P. Molinaro, G. Di Renzo, and L. Annunziato The Two Isoforms of the Na+/Ca2+ Exchanger, NCX1 and NCX3, Constitute Novel Additional Targets for the Prosurvival Action of Akt/Protein Kinase B Pathway Mol. Pharmacol., March 1, 2008; 73(3): 727 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Cuomo, R. Gala, G. Pignataro, F. Boscia, A. Secondo, A. Scorziello, A. Pannaccione, D. Viggiano, A. Adornetto, P. Molinaro, et al. A Critical Role for the Potassium-Dependent Sodium-Calcium Exchanger NCKX2 in Protection against Focal Ischemic Brain Damage J. Neurosci., February 27, 2008; 28(9): 2053 - 2063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Molinaro, O. Cuomo, G. Pignataro, F. Boscia, R. Sirabella, A. Pannaccione, A. Secondo, A. Scorziello, A. Adornetto, R. Gala, et al. Targeted Disruption of Na+/Ca2+ Exchanger 3 (NCX3) Gene Leads to a Worsening of Ischemic Brain Damage J. Neurosci., January 30, 2008; 28(5): 1179 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Obrenovitch Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia Physiol Rev, January 1, 2008; 88(1): 211 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Cuomo, G. Pignataro, R. Gala, A. Scorziello, E. Gravino, O. Piazza, R. Tufano, G. Di Renzo, and L. Annunziato Antithrombin Reduces Ischemic Volume, Ameliorates Neurologic Deficits, and Prolongs Animal Survival in Both Transient and Permanent Focal Ischemia Stroke, December 1, 2007; 38(12): 3272 - 3279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tortiglione, B. Picconi, I. Barone, D. Centonze, S. Rossi, C. Costa, M. Di Filippo, A. Tozzi, M. Tantucci, G. Bernardi, et al. Na+/Ca2+ Exchanger Maintains Ionic Homeostasis in the Peri-Infarct Area Stroke, May 1, 2007; 38(5): 1614 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Annunziato, M. Cataldi, G. Pignataro, A. Secondo, and P. Molinaro Glutamate-Independent Calcium Toxicity: Introduction Stroke, February 1, 2007; 38(2): 661 - 664. [Full Text] [PDF]
|
|
|
|
|
|
D. Bano and P. Nicotera Ca2+ Signals and Neuronal Death in Brain Ischemia Stroke, February 1, 2007; 38(2): 674 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pignataro, R. P. Simon, and Z.-G. Xiong Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia Brain, January 1, 2007; 130(1): 151 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iwamoto and S. Kita YM-244769, a Novel Na+/Ca2+ Exchange Inhibitor That Preferentially Inhibits NCX3, Efficiently Protects against Hypoxia/Reoxygenation-Induced SH-SY5Y Neuronal Cell Damage Mol. Pharmacol., December 1, 2006; 70(6): 2075 - 2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Magi, P. Castaldo, G. Carrieri, A. Scorziello, G. Di Renzo, and S. Amoroso Involvement of Na+-Ca2+ Exchanger in Intracellular Ca2+ Increase and Neuronal Injury Induced by Polychlorinated Biphenyls in Human Neuroblastoma SH-SY5Y Cells J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 291 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Annunziato, G. Pignataro, and G. F. Di Renzo Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives Pharmacol. Rev., December 1, 2004; 56(4): 633 - 654. [Abstract] [Full Text] [PDF]
|
|